Analysis of VEGF, IGF1/2 and the Long Noncoding RNA (lncRNA) H19 Expression in Polish Women with Endometriosis

Area of Science:

• Reproductive biology
• Molecular genetics
• Gynecology

Background:

• Endometriosis is a complex gynecological condition.
• Vascular Endothelial Growth Factor (VEGF), Insulin-like Growth Factor 1/2 (IGF1/2), and H19 gene expression are implicated in endometriosis pathogenesis.
• Understanding the specific roles of these factors is crucial for diagnosis and treatment.

Purpose of the Study:

• To investigate and compare the gene expression levels of VEGF, IGF1, and H19 in patients with endometriosis versus a control group.
• To analyze the correlation between the expression levels of these genes and the clinical stages of endometriosis.

Main Methods:

• Gene expression analysis using Reverse Transcription Polymerase Chain Reaction (RT-PCR).
• Study included 100 patients diagnosed with endometriosis and 100 controls.
• Patients were categorized into clinical stages 1-2 and 3-4 for endometriosis.

Main Results:

• VEGF gene expression was significantly higher in clinical stages 1-2 endometriosis compared to controls (p < 0.05) and stages 3-4 (p < 0.01).
• IGF1 gene expression was significantly lower in both clinical stages 1-2 and 3-4 endometriosis compared to controls (p < 0.05).
• H19 gene expression was significantly lower in clinical stage 3-4 endometriosis compared to controls (p < 0.01).

Conclusions:

• VEGF, IGF1, and H19 gene expression patterns are significantly altered in endometriosis.
• These molecular changes suggest critical roles for VEGF, IGF1, and H19 in the development and progression of endometriosis.
• The distinct expression profiles may serve as potential biomarkers for endometriosis staging.